Given the antiproliferative and antimigratory properties of CAPS on different MM lines, we investigated the effect of CAPS on the activation of AKT and ERK1/2, serine-threonine kinases involved in various cellular mechanisms such as cell proliferation, survival and migration [41,42]. The gene discussed is MAPK3; the disease is Miyoshi myopathy.